02.05.25 -- How 'Explainable ML' Can Improve Process Performance

The global market for injectable drugs will reach $69.13 billion by 2028. Examine the vital role of laminar airflow technology in meeting sterile integrity standards and minimizing contamination risks.

Tired of manual manipulation risks in biopharmaceuticals? Automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.

Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

Learn more about an effective, biodegradable solution for the viral inactivation process that controls protein impurities and is compatible with downstream unit operations.

Proper packing for resin is crucial to prevent issues like cracking or channeling which can lead to process disruptions and product loss.

Watch to learn about the various levels of intensification, core technologies used in the industry, and the impact of each level on productivity through a monoclonal antibody (mAb) platform.

Explore how the bYlok® bispecific pairing technology can be used to solve heavy-light chain mispairing in bispecific antibodies and how it compares with alternative scaffolds.

Is the mAb purification process limiting your progress and productivity? Using a ceramic hydroxyapatite could help address an inability to achieve proper clearance of impurities.

Delve into a study that examines the possibility of the combination of NK-cell-derived EVs and CBP as a viable immunochemotherapeutic strategy for resistant cancers.